Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 736 (ZNF736) is a member of the zinc finger protein superfamily, characterized by the presence of C2H2-type zinc finger domains and a KRAB (Krüppel-associated box) domain, typically associated with transcriptional repression. Zinc finger proteins are among the most abundant transcription factors in eukaryotes and play key roles in DNA binding, gene regulation, chromatin remodeling, and cellular differentiation[2][3][1]. ZNF736 encodes a protein predicted to function primarily in transcription regulation, likely through sequence-specific DNA binding and gene silencing via its KRAB domain. It has been linked through genetic association to rare congenital skeletal disorders such as metatropic dysplasia and brachyolmia, but there is presently no evidence to support its use as a therapeutic drug target or biomarker in clinical practice[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 736 (ZNF736).